These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39310403)

  • 1. CT-Guided Online Adaptive Radiotherapy Delivered via Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for a Bulky Thoracic and Abdominal Mass in Oligometastatic Renal Cell Carcinoma.
    Kassardjian AA; Ladbury C; Maraghechi B; Shi C; Watkins T; Liu A; Tsai K; Williams T; Li YR; Dandapani S; Schwer A; Lee P
    Cureus; 2024 Aug; 16(8):e67502. PubMed ID: 39310403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex Multi-site Stereotactic Body Re-irradiation With CT-Guided Online Adaptive Radiotherapy.
    Sievert D; D'Souza A; Zhao X; Prusator MT; Mazur T; Kim H; Hobbis D
    Cureus; 2024 Sep; 16(9):e68559. PubMed ID: 39364455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-guided online adaptive stereotactic body radiotherapy for pancreas ductal adenocarcinoma: Dosimetric and initial clinical experience.
    Lee A; Pasetsky J; Lavrova E; Wang YF; Sedor G; Li FL; Gallitto M; Garrett M; Elliston C; Price M; Kachnic LA; Horowitz DP
    Clin Transl Radiat Oncol; 2024 Sep; 48():100813. PubMed ID: 39149753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
    El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
    Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive-Driven CT Simulation-Free Soft Tissue Stereotactic Body Radiation Therapy: A Single-Patient Case Report.
    Veres MR; Sharifzadeh Y; Kavanaugh JA; Park S; Malkov V
    Cureus; 2024 Aug; 16(8):e66876. PubMed ID: 39280393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases.
    Schiff JP; Stowe HB; Price A; Laugeman E; Hatscher C; Hugo GD; Badiyan SN; Kim H; Robinson CG; Henke LE
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1022-1031. PubMed ID: 35768023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
    Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy for Oligometastatic Lung Adenocarcinoma: Leveraging CT-Guided Online Adaptive Radiotherapy.
    Eustace N; Ladbury C; Liu Y; Amini A; Sampath S; Watkins T; Tsai K; Maraghechi B; Han C; Shi C; Liu A; Williams T; Lee P
    Cureus; 2024 Aug; 16(8):e66877. PubMed ID: 39280455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.
    Henke LE; Olsen JR; Contreras JA; Curcuru A; DeWees TA; Green OL; Michalski J; Mutic S; Roach MC; Bradley JD; Parikh PJ; Kashani R; Robinson CG
    Adv Radiat Oncol; 2019; 4(1):201-209. PubMed ID: 30706029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive Stereotactic Body Radiation Therapy in the Management of Oligometastatic Uterine Leiomyosarcoma: A Clinical Case Report.
    Lubas MJ; Panetta J; Freeman R; Meyer JE
    Cureus; 2024 Sep; 16(9):e68572. PubMed ID: 39371748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
    Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
    Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
    Waters M; Price A; Laugeman E; Henke L; Hugo G; Stowe H; Andruska N; Brenneman R; Hao Y; Green O; Robinson C; Gay H; Michalski J; Baumann BC
    Clin Transl Radiat Oncol; 2024 Jan; 44():100693. PubMed ID: 38021093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Split-Course Adaptive Radioimmunotherapy for Oligometastatic Non-Small Cell Lung Cancer (SiCARIO): A Case Report.
    McComas KN; Masick SE; Yock AD; Whitaker RM
    Cureus; 2024 Sep; 16(9):e68868. PubMed ID: 39376864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
    Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
    Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.